Seeking Alpha

ACUR
Acura Pharmaceuticals, Inc.

5/27/2012, 11:46 AM ET
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
ACUR Market Currents more »
  • March 2 Acura Pharmaceuticals (ACUR) announces that independent testing of its Nexafed pseudoephedrine tablet shows that it has the ability to disrupt the illegal extraction of pseudoephedrine for the potential use of methamphetamine.
    Comment!
    [Healthcare]
ACUR in Focus more »
ACUR Latest Transcript more »
Currently, there are no transcripts for ACUR.
ACUR Cramer more »
Currently, there are no Cramer articles on ACUR.
ACUR Instablog posts more »
  • What's Inside Our Daily Updates - Daily Biotech Milestones and Clinical Trial Data
    Wed, Jun 16, 2010 • Andrew Nava • Comment!
Write a post on ACUR
ACUR StockTalks
ACUR vs. ETF Alternatives
Company Description
Currently, there's no company description for ACUR.